JHVEPhoto/iStock Editorial via Getty Images Shares of CVS Health ( NYSE: CVS ) lost ~8% in the premarket on Friday after The Wall Street Journal reported a leadership transition and below-consensus Q3 earnings at the pharmacy chain operator. According to the Journal , David Joyner, a longtime CVS executive, could replace the company’s.
Back to Health Page
